| RS2515995820 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2515995877 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2515997041 |
ARFGEF2
|
Health Risk |
Likely pathogenic |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS2516002006 |
PLCB4
|
Health Risk |
Pathogenic |
Auriculocondylar syndrome 2, Auriculocondylar syndrome 2 |
| RS2516003230 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2516003581 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypercholesterolemia |
| RS2516003630 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2516003967 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2516004003 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2516004016 |
LDLR
|
Health Risk |
Likely pathogenic |
Abnormal circulating lipid concentration, Familial hypercholesterolemia |
| RS2516004084 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2516004430 |
LDLR
|
Health Risk |
Pathogenic |
Abnormal circulating lipid concentration, Abnormal circulating lipid concentration |
| RS2516005181 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Familial hypercholesterolemia |
| RS2516005636 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2516005878 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2516006288 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS2516006825 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2516015591 |
COL9A3
|
Health Risk |
Pathogenic |
— |
| RS2516029074 |
COL9A3
|
Health Risk |
Pathogenic |
Stickler syndrome, type 6 |
| RS2516030998 |
COL9A3
|
Health Risk |
Likely pathogenic |
Epiphyseal dysplasia, multiple |
| RS2516037509 |
COL9A3
|
Health Risk |
Pathogenic |
— |
| RS2516041786 |
TAF4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 73 |
| RS2516043040 |
ARFGEF2
|
Health Risk |
Pathogenic |
— |
| RS2516055830 |
LAMA5
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, IIa 26 |
| RS2516057594 |
COL9A3
|
Health Risk |
Pathogenic |
— |
| RS2516077994 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516079854 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516081224 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2516083955 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516084081 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516087034 |
COL9A3
|
Health Risk |
Likely pathogenic |
— |
| RS2516089906 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516090212 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516090453 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516091019 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516091086 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516091356 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516091432 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516091525 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516092158 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2516092206 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516092247 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516093687 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516093868 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS2516094014 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516094689 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516094740 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516095055 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516095389 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516095868 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2516096143 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2516097737 |
KCNQ2
|
Health Risk |
Pathogenic |
KCNQ2-related disorder, KCNQ2-related disorder |
| RS2516098080 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2516098402 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516099742 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516100518 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2516100536 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516102200 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516102657 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516102768 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2516102833 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516104257 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2516104486 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516105014 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516105418 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516116135 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516116438 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516116469 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516117056 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516117275 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516117325 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516117508 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516117809 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516117976 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516118563 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516119319 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS2516119519 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516126445 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516139169 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2516141769 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
— |
| RS2516142077 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516142174 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
— |
| RS2516145103 |
PRPF31;PRPF31-AS1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS2516145631 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516151593 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516151783 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516152365 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516152792 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516152865 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516156843 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516157956 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516158518 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516158865 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinal dystrophy |
| RS2516159042 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516161339 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516161436 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516161597 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516161728 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516161732 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516164716 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |